[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-307366-105":3,"detail-sidebar-cat-1-en-105":81,"doc-detail-307366-en":127},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","very-low-risk-instructions-vlr-form-january-2026","Very Low Risk Instructions - VLR-Form - January 2026","","Very Low Risk Instructions (January 2026) define section-by-section requirements for completing a VLR project form. The instructions specify how to align the project title and renew the submission date for each revised form. They address which REB is primary, when outside REB amendments and documents are required, and the expected eligibility of the lead researcher. They also outline responsibilities for academic supervision, project team listing, funding disclosure, personal income funding details, release-of-funds requests, conflict of interest identification and management, and guidance on study objectives, participant interactions, and recruitment timelines.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/template/","Template",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/template/forms/","Forms",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/template/very-low-risk-instructions-vlr-form-january-2026/307366/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/very-low-risk-instructions-vlr-form-january-2026/307366.png","ImageObject",442,249,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-19",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How should the submission date be handled when submitting a revised form?","Question",{"text":63,"@type":64},"Renew the submission date every time you submit a revised form. CUREB uses this version date to identify the order of revised submissions and the most recent one.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What documents are needed when Carleton is not the primary REB for the study?",{"text":68,"@type":64},"If Carleton is not the primary REB and another REB approved first, submit the outside REB’s amendment approval letter along with all associated study documents (consent and recruitment materials, instruments, debriefing forms, and others). If the outside institution’s main protocol form provides substantially the same information as the corresponding CUREB form, you may submit the outside form instead.",{"name":70,"@type":61,"acceptedAnswer":71},"What must be disclosed regarding conflict of interest?",{"text":72,"@type":64},"Conflicts must be disclosed and managed to ensure personal or financial factors do not affect study conduct. Examples include financial benefit from research success, achieving recruitment targets for personal benefit, or ownership stakes in a company that may benefit. In many cases, informing participants in consent materials may be sufficient, but additional conflict management strategies may be needed; contact the REB early to discuss disclosure or steps.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},307366,1791515821,{"code":4,"msg":82,"data":83},"success",[84,89,94,99,104,109,113,118,123],{"id":85,"doc_module":22,"doc_module_name":25,"category_name":86,"show_sort_weight":87,"slug":88},11,"Presentations",90,"presentations",{"id":90,"doc_module":22,"doc_module_name":25,"category_name":91,"show_sort_weight":92,"slug":93},12,"Resumes",80,"resumes",{"id":95,"doc_module":22,"doc_module_name":25,"category_name":96,"show_sort_weight":97,"slug":98},14,"Invoices",70,"invoices",{"id":100,"doc_module":22,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},15,"Posters",60,"posters",{"id":105,"doc_module":22,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},16,"Social Media",50,"social-media",{"id":110,"doc_module":22,"doc_module_name":25,"category_name":29,"show_sort_weight":111,"slug":112},17,40,"forms",{"id":114,"doc_module":22,"doc_module_name":25,"category_name":115,"show_sort_weight":116,"slug":117},18,"Letters",30,"letters",{"id":119,"doc_module":22,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},21,"Paper Templates",5,"papers-templates",{"id":124,"doc_module":22,"doc_module_name":25,"category_name":125,"show_sort_weight":4,"slug":126},158,"General","general-158",{"code":4,"msg":82,"data":128},{"doc_id":79,"user_id":129,"nickname":42,"user_avatar":130,"doc_module":22,"category_id":110,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":136,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":12,"update_tm":140,"read_time":33},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","| Very Low Risk Instructions (January 2026) |  |  |\n| --- | --- | --- |\n| Section \\# | Section Heading | Instructions for Section |\n| 1A | Project Title | The Project Title should match the title shown on all study-related documents. |\n| 1B | Submission Date | Please renew this submission date every time you submit a revised Form. CUREB uses this version date to identify the order of revised submissions, and to identify the most recent one. |\n| 1C | Is Carleton the Primary REB for the Study? | For projects in which Carleton is not the primary REB and another REB, sometimes called the Board of Record, gave study approval first, then the primary REB should have approved the study before submitting to Carleton. Accordingly, if you answered No, include the outside REB's amendment approval letter along with all associated study documents (consent and recruitment materials, study data collection instruments, debriefing forms and others) . If the main protocol form from the outside instutution gives substantially the same information asthe corresponding CUREB form, then you may submit the outside form instead. In these circumstances, the Carleton REB approval process is somewhat expedited and may be faster than if Carleton is doing the primary review. |\n|  |  |  |\n| 2A | Lead Researcher | The Lead Researcher must, except in unusual circumstances, be a member of the Carleton research community. Please contact us at ethics@carleton.ca if you will propose an outside person as Lead Researcher. |\n| 2B | Academic Supervisor | All students and Post-docs must have an academic supervisor who is a Carleton Faculty Member. If there is more than one supervisor, identify the primary supervisor here, and include other(s) in 2C Project Team Members. The REB must have a signed REB Supervisor Approval Form, found here: [https://research.carleton.ca/cu-file/supervisor-sponsor-signature-form/](https://research.carleton.ca/cu-file/supervisor-sponsor-signature-form/) |\n| 2C | Project Team Members | List the project team members here including co-Investigators, collaborators, research assistants, etc. , and the information requested. The REB will normally correspond, and send notices to the Lead Researcher and the Academic Supervisor, if any. If you wish to have any other research team members receive messages from the REB, please indicate which, if any. |\n| 2D | Project Funding | The REB requires information on study funding in order to communicate with the Carleton Office for Research Initiatives & Services (CORIS) or IPS, or in case there is an appearance of conflict of interest.\u003Cbr>It is not unethical to receive funding from, for example, a company that benefits from the research. However, conflict of interest considerations dictate generally that participants need to be aware of the funding source, and the potential for commercial benefit. |\n| 2E | Researcher Funding (for research contracts and personal consulting only) | List who will be receiving any funds directly as personal income, how much they will receive, and indicate the percentage of the total funding awarded. This section does not require disclosure of normal and usual employment, compensation or support to students and other research associates assisting with the study.\u003Cbr>The REB uses this information to inform decisions on conflict of interest. While it is not unethical to receive personal income, the possibility of conflict must be considered and disclosed to participants. |\n| 2F | Request to Release Funds | A request to release funds is sometimes submitted when a research team needs to access funding prior to any involvement of human participants. If a researcher has been cleared for a release of funds by CUREB, please check the 'Yes' box and provide the 6 digit release of funds protocol number. This number can be found on CuResearch or within the clearance certificate for the release of funds file. |\n\n\n| 2G | Conflict of Interest | Conflicts of interest occur where any researcher ha","cbCailmJdI8YUoKa","https://ap.wps.com/l/cbCailmJdI8YUoKa","pdf",150398,"English","# Section 1 - Project information\n## 1A Project Title\n## 1B Submission Date\n## 1C Is Carleton the Primary REB for the Study?\n# Section 2 - Research team and funding\n## 2A Lead Researcher\n## 2B Academic Supervisor\n## 2C Project Team Members\n## 2D Project Funding\n## 2E Researcher Funding\n## 2F Request to Release Funds\n## 2G Conflict of Interest\n# Section 3 - Study scope and participants\n## 3A Study Objectives\n## 3B Overview of Participant Interactions\n## 3C Dates of Recruitment and Participant Interaction","[{\"question\":\"How should the submission date be handled when submitting a revised form?\",\"answer\":\"Renew the submission date every time you submit a revised form. CUREB uses this version date to identify the order of revised submissions and the most recent one.\"},{\"question\":\"What documents are needed when Carleton is not the primary REB for the study?\",\"answer\":\"If Carleton is not the primary REB and another REB approved first, submit the outside REB’s amendment approval letter along with all associated study documents (consent and recruitment materials, instruments, debriefing forms, and others). If the outside institution’s main protocol form provides substantially the same information as the corresponding CUREB form, you may submit the outside form instead.\"},{\"question\":\"What must be disclosed regarding conflict of interest?\",\"answer\":\"Conflicts must be disclosed and managed to ensure personal or financial factors do not affect study conduct. Examples include financial benefit from research success, achieving recruitment targets for personal benefit, or ownership stakes in a company that may benefit. In many cases, informing participants in consent materials may be sufficient, but additional conflict management strategies may be needed; contact the REB early to discuss disclosure or steps.\"}]","Very Low Risk Instructions - VLR-Form - January 2026 | PDF",1789848406]